Received Jul 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5Y4TL | — |
a patient was given only the diluent portion of the Shingrix vaccine; a patient was given only the diluent portion of the Shingrix vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 51-year-old female patient who received Herpes zoster (Shingrix) (batch number 5Y4TL, expiry date 31-JAN-2027) for prophylaxis. On 27-JUN-2025, the patient received Shingrix. On 27-JUN-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: a patient was given only the diluent portion of the Shingrix vaccine) and inappropriate dose of vaccine administered (Verbatim: a patient was given only the diluent portion of the Shingrix vaccine). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 30-JUN-2025 Nurse called today June 30, 2025 to report on June 27, 2025 a patient was given only the diluent portion of the Shingrix vaccine, situation was discovered and right after a correctly reconstituted dose was administered to the patient on the same arm which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.